[Mondor's thrombophlebitis and antiphospholipid antibodies].
Magy
Nadine
N
Gil
Helder
H
Racadot
Evelyne
E
Dupond
Jean-Louis
JL
D000328:Adult; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage / Q000627:therapeutic use; D017152:Antibodies, Antiphospholipid; D016736:Antiphospholipid Syndrome / Q000175:diagnosis*; D001241:Aspirin / Q000008:administration & dosage / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D005343:Fibrinolytic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D005500:Follow-Up Studies; D019693:Hepatitis, Autoimmune / Q000150:complications*; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000150:complications*; D008875:Middle Aged; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use; D013577:Syndrome; D013924:Thrombophlebitis / Q000175:diagnosis* / Q000188:drug therapy; D013997:Time Factors
D000894:Anti-Inflammatory Agents, Non-Steroidal; D017152:Antibodies, Antiphospholipid; D005343:Fibrinolytic Agents; D010975:Platelet Aggregation Inhibitors; D001241:Aspirin